Effect of Co-Grinding on Crystallinity of Clopidogrel Bisulfate

Csaba Mártha, Orsolya Jójárt-Laczkovich, P. Szabó-Révész

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A high energy input during pharmaceutical formulation is capable of decreasing the crystallinity of compounds in the product. The presence of the amorphous form can cause serious problems at any stage of the formulation. Crystallinity changes of a model powder mixture containing clopidogrel bisulfate (CLP) and a colloidal silicon dioxide as additive were investigated during a long-time co-grinding process. The crystallinity of CLP was reduced sigmoidally by co-grinding with longer co-grinding time. X-ray powder diffraction and differential scanning calorimetry examinations confirmed that the product had become totally amorphous after four hours of grinding. Thermogravimetric results proved that no major mass reduction happened and FT-IR changes referred to formulation of a secondary bond between the components.

Original languageEnglish
Pages (from-to)1393-1398
Number of pages6
JournalChemical Engineering and Technology
Volume37
Issue number8
DOIs
Publication statusPublished - 2014

Fingerprint

clopidogrel
Silicon Dioxide
Powders
X ray powder diffraction
Drug products
Differential scanning calorimetry
Silica
Pharmaceutical Preparations

Keywords

  • Clopidogrel bisulfate
  • Co-grinding
  • Crystallinity
  • FT-IR

ASJC Scopus subject areas

  • Chemical Engineering(all)
  • Chemistry(all)
  • Industrial and Manufacturing Engineering

Cite this

Effect of Co-Grinding on Crystallinity of Clopidogrel Bisulfate. / Mártha, Csaba; Jójárt-Laczkovich, Orsolya; Szabó-Révész, P.

In: Chemical Engineering and Technology, Vol. 37, No. 8, 2014, p. 1393-1398.

Research output: Contribution to journalArticle

Mártha, Csaba ; Jójárt-Laczkovich, Orsolya ; Szabó-Révész, P. / Effect of Co-Grinding on Crystallinity of Clopidogrel Bisulfate. In: Chemical Engineering and Technology. 2014 ; Vol. 37, No. 8. pp. 1393-1398.
@article{f4278d2bae8747388d00abd507302fb9,
title = "Effect of Co-Grinding on Crystallinity of Clopidogrel Bisulfate",
abstract = "A high energy input during pharmaceutical formulation is capable of decreasing the crystallinity of compounds in the product. The presence of the amorphous form can cause serious problems at any stage of the formulation. Crystallinity changes of a model powder mixture containing clopidogrel bisulfate (CLP) and a colloidal silicon dioxide as additive were investigated during a long-time co-grinding process. The crystallinity of CLP was reduced sigmoidally by co-grinding with longer co-grinding time. X-ray powder diffraction and differential scanning calorimetry examinations confirmed that the product had become totally amorphous after four hours of grinding. Thermogravimetric results proved that no major mass reduction happened and FT-IR changes referred to formulation of a secondary bond between the components.",
keywords = "Clopidogrel bisulfate, Co-grinding, Crystallinity, FT-IR",
author = "Csaba M{\'a}rtha and Orsolya J{\'o}j{\'a}rt-Laczkovich and P. Szab{\'o}-R{\'e}v{\'e}sz",
year = "2014",
doi = "10.1002/ceat.201400120",
language = "English",
volume = "37",
pages = "1393--1398",
journal = "Chemical Engineering and Technology",
issn = "0930-7516",
publisher = "Wiley-VCH Verlag",
number = "8",

}

TY - JOUR

T1 - Effect of Co-Grinding on Crystallinity of Clopidogrel Bisulfate

AU - Mártha, Csaba

AU - Jójárt-Laczkovich, Orsolya

AU - Szabó-Révész, P.

PY - 2014

Y1 - 2014

N2 - A high energy input during pharmaceutical formulation is capable of decreasing the crystallinity of compounds in the product. The presence of the amorphous form can cause serious problems at any stage of the formulation. Crystallinity changes of a model powder mixture containing clopidogrel bisulfate (CLP) and a colloidal silicon dioxide as additive were investigated during a long-time co-grinding process. The crystallinity of CLP was reduced sigmoidally by co-grinding with longer co-grinding time. X-ray powder diffraction and differential scanning calorimetry examinations confirmed that the product had become totally amorphous after four hours of grinding. Thermogravimetric results proved that no major mass reduction happened and FT-IR changes referred to formulation of a secondary bond between the components.

AB - A high energy input during pharmaceutical formulation is capable of decreasing the crystallinity of compounds in the product. The presence of the amorphous form can cause serious problems at any stage of the formulation. Crystallinity changes of a model powder mixture containing clopidogrel bisulfate (CLP) and a colloidal silicon dioxide as additive were investigated during a long-time co-grinding process. The crystallinity of CLP was reduced sigmoidally by co-grinding with longer co-grinding time. X-ray powder diffraction and differential scanning calorimetry examinations confirmed that the product had become totally amorphous after four hours of grinding. Thermogravimetric results proved that no major mass reduction happened and FT-IR changes referred to formulation of a secondary bond between the components.

KW - Clopidogrel bisulfate

KW - Co-grinding

KW - Crystallinity

KW - FT-IR

UR - http://www.scopus.com/inward/record.url?scp=84904791680&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904791680&partnerID=8YFLogxK

U2 - 10.1002/ceat.201400120

DO - 10.1002/ceat.201400120

M3 - Article

VL - 37

SP - 1393

EP - 1398

JO - Chemical Engineering and Technology

JF - Chemical Engineering and Technology

SN - 0930-7516

IS - 8

ER -